Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Clinical trial NCT04775706 · RECRUITING

Trial details

NCT number: NCT04775706
Sponsor: Hanmi Pharmaceutical Company Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Short Bowel Syndrome

Start date: 2022-03-03
Primary completion: 2027-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.